GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BSF Enterprise PLC (OTCPK:BSFAF) » Definitions » Dividends per Share

BSFAF (BSF Enterprise) Dividends per Share : $0.00 (TTM As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is BSF Enterprise Dividends per Share?

BSF Enterprise's dividends per share for the six months ended in Sep. 2024 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00. Its Dividend Payout Ratio for the six months ended in Sep. 2024 was 0.00. As of today, BSF Enterprise's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


BSF Enterprise Dividends per Share Historical Data

The historical data trend for BSF Enterprise's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BSF Enterprise Dividends per Share Chart

BSF Enterprise Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Dividends per Share
Get a 7-Day Free Trial - - - - -

BSF Enterprise Semi-Annual Data
Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BSF Enterprise's Dividends per Share

For the Biotechnology subindustry, BSF Enterprise's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BSF Enterprise's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BSF Enterprise's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where BSF Enterprise's Dividend Yield % falls into.


;
;

BSF Enterprise Dividends per Share Calculation

Dividends paid to per common share.


BSF Enterprise  (OTCPK:BSFAF) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

BSF Enterprise's Dividend Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Sep. 2024 )/ EPS without NRI (Q: Sep. 2024 )
=0/ -0.01
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BSF Enterprise Dividends per Share Related Terms

Thank you for viewing the detailed overview of BSF Enterprise's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


BSF Enterprise Business Description

Traded in Other Exchanges
Address
2 Portman Street, London, GBR, W1H 6DU
BSF Enterprise PLC is a United Kingdom-based biotech company. The Company is focused on developing biotechnological solutions using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes. The Company operates through its wholly owned subsidiary, 3D Bio-Tissues Limited (3DBT), which is a clinical and cellular agriculture company engaged in producing human corneas that could help restore vision to millions of people.

BSF Enterprise Headlines

From GuruFocus